Airway Management: The Case for
Routine Video-laryngoscopy

 

Date:

September 10th @12 PM ET

 

Speaker:

Barry L. Friedberg, M.D. 

 

                        

 

Description:

The use of opioids in modern anesthesia has been an article of faith for more than a century. Opioid-free anesthesia (OFA) can be considered heresy that challenges the current thinking, however OFA has provided improved patient outcomes for nearly 30 years. Opioid-inclusive anesthesia not only fails to prevent postoperative pain, but also increases postoperative nausea and vomiting, respiratory depression, and opioid rescue. Sedated patients breathe spontaneously and can move. This presentation focuses on OFA for IV sedation and applies OFA principles applicable to general anesthesia.

 

Learning Objectives:

Upon completion of this educational activity, the participant will be able to:

  1. Discuss Incremental propofol induction

  2. Describe Ketamine side-effect avoidance

  3. Discuss how to differentiate between purposeful and non-purposeful patient movement.

 

Faculty Bio:

Dr. Friedberg is a board-certified anesthesiologist. He is a long-time advocate of opioid free, brain monitored anesthesia. His propofol ketamine paradigm was adopted by the US military for anesthesia machine-free, advanced field anesthesia for which he received a US Congressional Award. Prior to brain monitoring, his first fifteen years were marked by early technology adaptation of the non-invasive blood pressure device, cardiac output computer, and pulse oximeter. He served as adjuvant faculty at both the University of Southern California and University of California Irvine. He is a well-traveled national and international speaker, most recently in Abu Dhabi and Dubai. 

This continuing education program is sponsored by Covidien LP, a subsidiary of Medtronic, and is an provider approved by
the Commission on Accreditation for Prehospital Continuing Education

Continuing Education for Physicians, Nurses, and Respiratory Therapists

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Creditâ„¢. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

 

Support for this educational activity from Medtronic